Ann Culkin

1.6k total citations · 1 hit paper
6 papers, 1.2k citations indexed

About

Ann Culkin is a scholar working on Oncology, General Health Professions and Genetics. According to data from OpenAlex, Ann Culkin has authored 6 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in General Health Professions and 1 paper in Genetics. Recurrent topics in Ann Culkin's work include Cancer survivorship and care (2 papers), Meta-analysis and systematic reviews (1 paper) and Psychosomatic Disorders and Their Treatments (1 paper). Ann Culkin is often cited by papers focused on Cancer survivorship and care (2 papers), Meta-analysis and systematic reviews (1 paper) and Psychosomatic Disorders and Their Treatments (1 paper). Ann Culkin collaborates with scholars based in United States. Ann Culkin's co-authors include Ethan Basch, Deborah Schrag, Alexia Iasonos, Mark G. Kris, Allison Barz Leahy, Howard I. Scher, Tiffani L. McDonough, Shari Goldfarb, M. Fruscione and Xiaoyu Jia and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and The Lancet Oncology.

In The Last Decade

Ann Culkin

6 papers receiving 1.1k citations

Hit Papers

Adverse Symptom Event Reporting by Patients vs Clinicians... 2009 2026 2014 2020 2009 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Culkin United States 6 701 271 222 188 169 6 1.2k
Andrea Denicoff United States 22 801 1.1× 385 1.4× 204 0.9× 187 1.0× 248 1.5× 69 1.5k
James Holland United States 6 640 0.9× 249 0.9× 297 1.3× 194 1.0× 111 0.7× 6 1.3k
Michael Montello United States 13 770 1.1× 579 2.1× 343 1.5× 517 2.8× 227 1.3× 26 2.0k
Johan Ahlgren Sweden 23 1.0k 1.4× 281 1.0× 253 1.1× 255 1.4× 140 0.8× 68 1.7k
Lynn Ries United States 12 927 1.3× 265 1.0× 321 1.4× 348 1.9× 134 0.8× 12 1.9k
C. Langridge United Kingdom 18 535 0.8× 437 1.6× 128 0.6× 165 0.9× 169 1.0× 29 1.5k
Magdalena Bielska‐Lasota Poland 10 1.0k 1.5× 200 0.7× 399 1.8× 94 0.5× 183 1.1× 26 1.8k
Kristen K. McNiff United States 19 669 1.0× 605 2.2× 145 0.7× 356 1.9× 476 2.8× 50 1.6k
Michael N. Neuss United States 19 608 0.9× 508 1.9× 160 0.7× 307 1.6× 404 2.4× 51 1.6k
Melisa L. Wong United States 20 728 1.0× 164 0.6× 599 2.7× 157 0.8× 97 0.6× 68 1.4k

Countries citing papers authored by Ann Culkin

Since Specialization
Citations

This map shows the geographic impact of Ann Culkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Culkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Culkin more than expected).

Fields of papers citing papers by Ann Culkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Culkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Culkin. The network helps show where Ann Culkin may publish in the future.

Co-authorship network of co-authors of Ann Culkin

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Culkin. A scholar is included among the top collaborators of Ann Culkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Culkin. Ann Culkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Basch, Ethan, Xiaoyu Jia, Glenn Heller, et al.. (2009). Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes. JNCI Journal of the National Cancer Institute. 101(23). 1624–1632. 480 indexed citations breakdown →
2.
Eaby, Beth, Ann Culkin, & Mario E. Lacouture. (2008). An Interdisciplinary Consensus on Managing Skin Reactions Associated With Human Epidermal Growth Factor Receptor Inhibitors. Clinical journal of oncology nursing. 12(2). 283–290. 50 indexed citations
3.
Joyce, Margaret M., et al.. (2008). Putting Evidence Into Practice®: Evidence-Based Interventions for Cancer-Related Dyspnea. Clinical journal of oncology nursing. 12(2). 341–352. 16 indexed citations
4.
Basch, Ethan, Alexia Iasonos, Allison Barz Leahy, et al.. (2007). Long-Term Toxicity Monitoring via Electronic Patient-Reported Outcomes in Patients Receiving Chemotherapy. Journal of Clinical Oncology. 25(34). 5374–5380. 146 indexed citations
5.
Basch, Ethan, Alexia Iasonos, Tiffani L. McDonough, et al.. (2006). Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. The Lancet Oncology. 7(11). 903–909. 488 indexed citations
6.
Basch, Ethan, Tiffani L. McDonough, Alexia Iasonos, et al.. (2006). Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events. Journal of Clinical Oncology. 24(18_suppl). 8515–8515. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026